1,395
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the relationship of the T and M stage with the erector spinae muscle area in male lung cancer patients

ORCID Icon & ORCID Icon
Article: 2154336 | Received 04 Oct 2022, Accepted 29 Nov 2022, Published online: 04 Mar 2023

References

  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA A Cancer J. Clin. 2021;71(1):7–33.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of ıncidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
  • Kay FU, Kandathil A, Batra K, et al. Revisions to the tumor, node, metastasis staging of lung cancer (8th edition): rationale, radiologic findings and clinical implications. World J Radiol. 2017;9(6):269–279.
  • Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203.
  • Rami-Porta R, Asamura H, Travis WD, et al. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138–155.
  • Stroobants SG, D'Hoore I, Dooms C, et al. Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer. Clin Lung Cancer. 2003;4(4):242–247.
  • Karatas F, Acat M, Sahin S, et al. The prognostic and predictive significance of serum thiols and disulfide levels in advanced non-small cell lung cancer. Aging Male. 2020;23(5):619–628.
  • Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799.
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised european consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
  • Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–1547.
  • Collins J, Noble S, Chester J, et al. The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open. 2014;4(1):e003697.
  • Yang M, Shen Y, Tan L, et al. Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest. 2019;156(1):101–111.
  • Ozeki N, Kawaguchi K, Fukui T, et al. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma. Int J Clin Oncol. 2020;25(5):876–884.
  • Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495.
  • Cho YH, Do KH, Chae EJ, et al. Association of chest CT-based quantitative measures of muscle and fat with post-lung transplant survival and morbidity: a single ınstitutional retrospective cohort study in korean population. Korean J Radiol. 2019;20(3):522–530.
  • Nakano A, Ohkubo H, Taniguchi H, et al. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis. Sci Rep. 2020;10(1):2312.
  • Kim CR, Kim EY, Kim YS, et al. Histologic subtypes are not associated with the presence of sarcopenia in lung cancer. PLoS One. 2018;13(3):e0194626.
  • Kim EY, Kim YJ, Kim YS, et al. Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer. J Thorac Dis. 2021;13(2):754–761.
  • Tanaka S, Ozeki N, Mizuno Y, et al. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2021;12(3):646–656.
  • Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: ımpact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260.
  • Meijer TW, Schuurbiers OC, Kaanders JH, et al. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4. Lung Cancer. 2012;76(3):316–323.
  • Pipek LZ, Baptista CG, Nascimento RFV, et al. The impact of properly diagnosed sarcopenia on postoperative outcomes after gastrointestinal surgery: a systematic review and meta-analysis. PLoS One. 2020;15(8):e0237740.
  • Wilson D, Jackson T, Sapey E, et al. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017;36:1–10.
  • Takahashi Y, Suzuki S, Hamada K, et al. Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer. Ann Transl Med. 2021;9(4):325.
  • Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health ABC study. J Gerontol A Biol Sci Med Sci. 2002;57(5):M326–M332.
  • Chemama S, Bayar MA, Lanoy E, et al. Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic ıntraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2016;23(12):3891–3898.
  • Huiskamp LFJ, Chargi N, Devriese LA, et al. The predictive value of low skeletal muscle mass assessed on cross-sectional ımaging for anti-cancer drug toxicity: a systematic review and meta-analysis. JCM. 2020;9(11):3780.
  • Tanimura K, Sato S, Fuseya Y, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. Novel chest computed tomography-derived ındex for prognosis. Ann Am Thorac Soc. 2016;13(3):334–341.
  • Canvasser LD, Mazurek AA, Cron DC, et al. Paraspinous muscle as a predictor of surgical outcome. J Surg Res. 2014;192(1):76–81.
  • Choi H, Park YS, Na KJ, et al. Association of adipopenia at preoperative PET/CT with mortality in stage I non-small cell lung cancer. Radiology. 2021;301(3):645–653.
  • Kinsey CM, San José Estépar R, van der Velden J, et al. Lower pectoralis muscle area Is associated with a worse overall survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2017;26(1):38–43.